46 results
Page 2 of 3
8-K
EX-99.1
1lzgcw8q
15 Nov 21
Mirum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.1
7654y
29 Sep 21
U.S. FDA Approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome One Year of Age and Older
4:42pm
8-K
EX-99.1
fp9dzgln
20 Aug 21
Mirum Pharmaceuticals Appoints Biotechnology Executive William C. Fairey to its Board of Directors
12:00am
8-K
EX-99.1
mbghryiqmn
9 Jun 21
Mirum Pharmaceuticals Appoints Veteran Biotechnology Executive Carol L. Brosgart, M.D. to Board of Directors
4:17pm
DEF 14A
tbdvw5z
29 Apr 20
Definitive proxy
4:15pm
10-K
afzrpuqzi3uh0zu08ijg
12 Mar 20
Annual report
4:16pm
424B4
myqb7r9n476d j9akp7x
9 Jan 20
Prospectus supplement with pricing info
5:11pm
DRS
2xki9jizfnh101fnd
27 Dec 19
Draft registration statement
12:00am
10-Q
s6a6h9kg7ggedj6fe
28 Aug 19
Quarterly report
4:21pm
424B4
n3lks3cg7o
18 Jul 19
Prospectus supplement with pricing info
4:04pm